NCT01805245

Brief Summary

The purpose of this study is to evaluate the impact of stress reduction on physiological and psychological variables in adults with Type 2 diabetes (T2DM) who have moderate to severe levels of diabetes-related emotional distress. Subjects will be randomized to one of two interventions. We will evaluate the impact of the interventions on glucose metabolism, blood pressure, diabetes-related distress and quality of life. Additionally, we will investigate the role of neuroendocrine dysfunction, systemic inflammation and diabetes self-care practices as mediators in the relationship between increased stress, adverse glucose metabolism and elevated blood pressure in those subjects with T2DM.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
78

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started Jan 2012

Longer than P75 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

January 1, 2012

Completed
6 months until next milestone

First Submitted

Initial submission to the registry

June 15, 2012

Completed
9 months until next milestone

First Posted

Study publicly available on registry

March 6, 2013

Completed
1.7 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

November 1, 2014

Completed
1.1 years until next milestone

Study Completion

Last participant's last visit for all outcomes

December 1, 2015

Completed
Last Updated

April 19, 2017

Status Verified

April 1, 2017

Enrollment Period

2.8 years

First QC Date

June 15, 2012

Last Update Submit

April 17, 2017

Conditions

Outcome Measures

Primary Outcomes (2)

  • HgA1c

    We will assess change in glycemic control using the A1c. It will be measured at baseline, immediately following the 8 week intervention and at 24 weeks from baseline.

    0,8,24 weeks

  • Diabetes Distress

    The Problem Areas in Diabetes will be used to assess the change in diabetes emotional distress at baseline, immediately following the 8 week intervention and at 24 weeks from baseline

    0,8,24 weeks

Secondary Outcomes (23)

  • SF36 Physical Health Score

    0, 8,24 weeks

  • SF36 Mental Health Score

    0,8,24 weeks

  • Mean 24 hour ambulatory systolic blood pressure

    0,8,24 weeks

  • Mean 24 hour diastolic ambulatory blood pressure

    0,8,24 weeks

  • HOMA-IR

    0,8,24 weeks

  • +18 more secondary outcomes

Other Outcomes (1)

  • Mindfulness

    0,8,24 weeks

Study Arms (2)

Mindfulness Based Stress Reduction

EXPERIMENTAL
Behavioral: Mindfulness Based Stress Reduction

Health Education Control

ACTIVE COMPARATOR
Behavioral: Mindfulness Based Stress Reduction

Interventions

Standard 8-week MBSR program; classes meet for 2.5 hours once weekly The health education control group meets at the same time and for the same amount of time

Health Education ControlMindfulness Based Stress Reduction

Eligibility Criteria

Age30 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Age \> 30 years
  • Male or female
  • Duration of diabetes 1-15 years from time of initial diagnosis
  • Diagnosis of T2DM made/confirmed by physician
  • Completed diabetes education in the past
  • Most recent HgA1c \>7%; measurement must be within the past 6 months either in physicians office or at the Thriving with Diabetes Boot Camp Class
  • Treatment for diabetes must include any or all of the following modalities:
  • diet, exercise, oral medications, insulin or other injectable diabetic medication
  • Score \> 30 on the Problem Area in Diabetes (PAID) Questionnaire
  • Able to use a glucometer for self-monitoring of blood glucose values
  • Most recent clinic blood pressure less than 180/95

You may not qualify if:

  • History of ketoacidosis
  • Age at diagnosis of T2DM \< 30 years
  • Score \>15 on the PHQ-9
  • Previous training in relaxation or meditation techniques
  • Current practice of yoga, tai chi or any other mind-body movement for \> 60 minutes per week
  • Current use of a psychoactive drug for less than 3 months or not yet on a stable dose
  • Inability to participate fully or behave appropriately in the group treatment setting, as observed by baseline acknowledgement of substance abuse, psychotic episode(s), psychiatric hospitalization or history of self- harm within the past 2 years, or current suicidal or homicidal ideation
  • Inability to complete standardized instruments because of a cognitive deficit or language barrier
  • Current use or use within the past 3 months of oral glucocorticoids, excluding intraocular, topical or inhaled preparations
  • History of inflammatory diseases including rheumatoid arthritis and inflammatory bowel disease
  • Use of immune modulating agents
  • Night shift work or other type of schedule in which sleep wake cycle is disrupted
  • Women who consume \> 7 alcoholic drinks per week and men who consume \> 14 drinks per week
  • Current use or history of daily tobacco use within the past 1 year
  • End stage renal failure on dialysis
  • +4 more criteria

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

University of North Carolina

Chapel Hill, North Carolina, 27599, United States

Location

MeSH Terms

Conditions

Diabetes Mellitus, Type 2

Interventions

Mindfulness-Based Stress Reduction

Condition Hierarchy (Ancestors)

Diabetes MellitusGlucose Metabolism DisordersMetabolic DiseasesNutritional and Metabolic DiseasesEndocrine System Diseases

Intervention Hierarchy (Ancestors)

MindfulnessCognitive Behavioral TherapyBehavior TherapyPsychotherapyBehavioral Disciplines and Activities

Study Officials

  • Laura A Young, MD, PhD

    University of North Carolina

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
OUTCOMES ASSESSOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

June 15, 2012

First Posted

March 6, 2013

Study Start

January 1, 2012

Primary Completion

November 1, 2014

Study Completion

December 1, 2015

Last Updated

April 19, 2017

Record last verified: 2017-04

Locations